The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nebivolol 10mg tablets

Glenmark Arzneimittel GmbHPA22645/002/001

Main Information

Trade NameNebivolol 10mg tablets
Active SubstancesNebivolol
Dosage FormTablet
Licence HolderGlenmark Arzneimittel GmbH
Licence NumberPA22645/002/001

Group Information

ATC CodeC07AB Beta blocking agents, selective
C07AB12 nebivolol


License statusAuthorised
Licence Issued17/01/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back